2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
June 28th 2022
Gregory Botta, MD, PhD, discusses unmet needs in the salvage setting of gastrointestinal cancers.
June 19th 2022
Gregory Botta, MD, PhD, discusses the rationale for investigating CT041 in patients with advanced gastric and pancreatic cancers in a phase 1b trial.
June 7th 2022
Gregory Botta, MD, PhD, discusses the evaluation of CT041 in patients with advanced gastric and pancreatic cancers in a phase 1b trial.
March 22nd 2022
Gregory P. Botta, MD, PhD, highlights key trials of interest exploring ctDNA analyses to better inform treatment decisions for patients with rectal cancers.
March 15th 2022
What to know about the design and results of the CIRCULATE-Japan study in colorectal cancer, in terms of using ctDNA analyses to help inform treatment decisions in the postoperative setting.
March 8th 2022
Current trials investigating the potential of ctDNA analyses in pancreatic cancer.
March 1st 2022
Dr Gregory P. Botta reacts to results of a study that recently explored the association of tumor-informed and personalized ctDNA with patient survival outcomes in pancreatic cancer, as presented at ASCO GI 2022.
February 22nd 2022
The potential clinical applications of ctDNA analyses in pancreatic cancer.